Patent ID: 8071573

Claim:
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of one or more compounds having the formula: or pharmaceutically acceptable salts thereof; wherein: X is â€”OH, or a halogen; n is 1, 2, or 3; R 1 -R 5 , independently of one another, are selected from the group consisting of a hydrogen, a halogen, a â€”CN, â€”OR 10 , â€”COOR 10 , â€”OCOOR 10 , â€”COR 10 , â€”CON(R 10 ) 2 , â€”OCON(R 10 ) 2 , â€”N(R 10 ) 2 , â€”NO 2 , â€”SR 10 , â€”SO 2 R 10 , â€”SO 2 N(R 10 ) 2 or â€”SOR 10 group, an optionally substituted alkyl group, an optionally substituted alkenyl group, and an optionally substituted aryl group, where each R 10 is selected from H, an optionally substituted alkyl group and an optionally substituted aryl group, an optionally substituted acyl group; R 6 and R 7 , independently of each other, are selected from the group consisting of a hydrogen, a halogen, a â€”N(R 11 ) 2 , or â€”SR 11 group, an optionally substituted alkyl group, an optionally substituted alkenyl group, an optionally substituted alkoxy group, and an optionally substituted aryl group, where each R 11 is selected from H, an optionally substituted alkyl group and an optionally substituted aryl group; and wherein R 6 and R 7 can together form a 3-7-member ring which may contain one or more double bonds.